Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 3;10(1):56.
doi: 10.1186/s13601-020-00366-3.

Highlights and recent developments in allergic diseases in EAACI journals (2019)

J Bousquet  1   2 , C E Grattan  3 , C A Akdis  4 , P A Eigenmann  5 , K Hoffmann-Sommergruber  6 , I Agache  7 , M Jutel  8   9
Affiliations
Review

Highlights and recent developments in allergic diseases in EAACI journals (2019)

J Bousquet et al. Clin Transl Allergy. .

Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members. There was substantial progress in 2019 in the identification of basic mechanisms of allergic and respiratory disease and the translation of these mechanisms into clinics. Better understanding of molecular and cellular mechanisms, efforts for the development of biomarkers for disease prediction, novel prevention and intervention studies, elucidation of mechanisms of multimorbidities, entrance of new drugs in the clinics as well as recently completed phase three clinical studies and publication of a large number of allergen immunotherapy studies and meta-analyses have been the highlights of the last year.

Keywords: Allergens; Anaphylaxis; Angioedema; Asthma; Atopic dermatitis; EAACI; Food allergy; Immunotherapy; Rhinitis; Urticaria.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Bousquet J, Akdis CA, Grattan C, Eigenmann PA, Hoffmann-Sommergruber K, Hellings PW, et al. Highlights and recent developments in airway diseases in EAACI journals (2017) Clin Transl Allergy. 2018;8:49. doi: 10.1186/s13601-018-0238-3. - DOI - PMC - PubMed
    1. Eigenmann PA, Akdis C, Bousquet J, Grattan CE, Hoffmann-Sommergruber K, Hellings PW, et al. Highlights and recent developments in food and drug allergy, and anaphylaxis in EAACI Journals (2017) Pediatr Allergy Immunol. 2018;29(8):801–807. doi: 10.1111/pai.12986. - DOI - PubMed
    1. Bousquet J, Akdis CA, Grattan C, Eigenmann PA, Hoffmann-Sommergruber K, Agache I, et al. Highlights and recent developments in airway diseases in EAACI journals (2018) Allergy. 2019;74(12):2329–2341. doi: 10.1111/all.14068. - DOI - PubMed
    1. Akdis CA, Bousquet J, Grattan CE, Eigenmann PA, Hoffmann-Sommergruber K, Agache I, et al. Highlights and recent developments in skin allergy and related diseases in EAACI journals (2018) Clin Transl Allergy. 2019;9:60. doi: 10.1186/s13601-019-0299-y. - DOI - PMC - PubMed
    1. Atanaskovic-Markovic M, Gomes E, Cernadas JR, du Toit G, Kidon M, Kuyucu S, et al. Diagnosis and management of drug-induced anaphylaxis in children: an EAACI position paper. Pediatr Allergy Immunol. 2019;30(3):269–276. doi: 10.1111/pai.13034. - DOI - PubMed